Literature DB >> 17658502

Cytotoxicity of honeybee (Apis mellifera) venom in normal human lymphocytes and HL-60 cells.

Young Joon Lee1, Su Jin Kang, Byeong Mo Kim, Yang Jee Kim, Hae Dong Woo, Hai Won Chung.   

Abstract

Whole bee venom (BV) is used to treat inflammatory diseases in Korean traditional medicine. Various studies have demonstrated anti-inflammatory and anticancer effects of BV. The toxicity of individual components of BV has been widely studied, although few studies have reported on the toxicity of BV. We sought to evaluate the cytotoxicity of BV in normal human lymphocytes and HL-60 cells. When cells were treated with BV at concentrations of 1 or 5 microg/ml, BV induced cell death in a time-dependent manner until 24 h, but these cytotoxic effects ended thereafter. When cells were treated with BV at a concentration of 10 microg/ml, however, viability decreased until 72 h, which may have been due to the half-life of BV. Whole BV also inhibited proliferation in these cells. BV induced DNA fragmentation and micronuclei in HL-60 cells and DNA fragmentation in human lymphocytes. Phosphate and tensin homolog (PTEN) up-regulation in HL-60 cells may induce S-phase cell cycle arrest. Forkhead transcription factor (FKHR and FKHRL1) up-regulation in human lymphocytes by whole BV treatment may be involved in the repair of damaged DNA and reduce genotoxicity. Based on these results, whole BV may exert cytotoxicity in these two cells in a different fashion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17658502     DOI: 10.1016/j.cbi.2007.06.036

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  10 in total

1.  Multistage Nanovectors Enhance the Delivery of Free and Encapsulated Drugs.

Authors:  Jonathan O Martinez; Michael Evangelopoulos; Rohan Bhavane; Stefania Acciardo; Francesco Salvatore; Xuewu Liu; Mauro Ferrari; Ennio Tasciotti
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

Review 2.  Helminthes and insects: maladies or therapies.

Authors:  Nora L El-Tantawy
Journal:  Parasitol Res       Date:  2014-12-30       Impact factor: 2.289

3.  Antitumour action on human glioblastoma A1235 cells through cooperation of bee venom and cisplatin.

Authors:  Goran Gajski; Tamara Čimbora-Zovko; Sanjica Rak; Maja Osmak; Vera Garaj-Vrhovac
Journal:  Cytotechnology       Date:  2015-04-28       Impact factor: 2.058

4.  Dimeric unnatural polyproline-rich peptides with enhanced antibacterial activity.

Authors:  Victor Hernandez-Gordillo; Iris Geisler; Jean Chmielewski
Journal:  Bioorg Med Chem Lett       Date:  2013-12-11       Impact factor: 2.823

5.  Pharmacological Screening of Venoms from Five Brazilian Micrurus Species on Different Ion Channels.

Authors:  Jessica Matos Kleiz-Ferreira; Hans Bernaerts; Ernesto Lopes Pinheiro-Junior; Steve Peigneur; Russolina Benedeta Zingali; Jan Tytgat
Journal:  Int J Mol Sci       Date:  2022-07-13       Impact factor: 6.208

Review 6.  A Review of Medicinal Plants of the Himalayas with Anti-Proliferative Activity for the Treatment of Various Cancers.

Authors:  Hailemeleak Regassa; Anuradha Sourirajan; Vikas Kumar; Sadanand Pandey; Deepak Kumar; Kamal Dev
Journal:  Cancers (Basel)       Date:  2022-08-12       Impact factor: 6.575

7.  The synergistic cytotoxic effect of cisplatin and honey bee venom on human ovarian cancer cell line A2780cp.

Authors:  Masoumehzaman Alizadehnohi; Mohammad Nabiuni; Zahra Nazari; Zahra Safaeinejad; Saeed Irian
Journal:  J Venom Res       Date:  2012-10-23

8.  Production of the first effective hyperimmune equine serum antivenom against Africanized bees.

Authors:  Keity Souza Santos; Marco Antonio Stephano; José Roberto Marcelino; Virginia Maria Resende Ferreira; Thalita Rocha; Celso Caricati; Hisako Gondo Higashi; Ana Maria Moro; Jorge Elias Kalil; Osmar Malaspina; Fabio Fernandes Morato Castro; Mário Sérgio Palma
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

9.  Combined cytogenotoxic effects of bee venom and bleomycin on rat lymphocytes: an in vitro study.

Authors:  Yasmina M Abd-Elhakim; Samah R Khalil; Ashraf Awad; Laila Y Al-Ayadhi
Journal:  Biomed Res Int       Date:  2014-04-16       Impact factor: 3.411

Review 10.  Apitoxin and Its Components against Cancer, Neurodegeneration and Rheumatoid Arthritis: Limitations and Possibilities.

Authors:  Andreas Aufschnaiter; Verena Kohler; Shaden Khalifa; Aida Abd El-Wahed; Ming Du; Hesham El-Seedi; Sabrina Büttner
Journal:  Toxins (Basel)       Date:  2020-01-21       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.